Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
Devastating Russian missile and drone attack strikes Kyiv and other Ukrainian regions, killing at least 15 and injuring over 100, as Zelenskyy seeks international support at G7 summit.
US homebuilder sentiment plunges to a 2.5-year low as price cuts and sales incentives rise amid economic uncertainty.
Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
Devastating Russian missile and drone attack strikes Kyiv and other Ukrainian regions, killing at least 15 and injuring over 100, as Zelenskyy seeks international support at G7 summit.
US homebuilder sentiment plunges to a 2.5-year low as price cuts and sales incentives rise amid economic uncertainty.